Prestige Consumer Healthcare Inc (NYSE:PBH) has received an average rating of “Hold” from the eight brokerages that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among brokers that have covered the stock in the last year is $57.88.
PBH has been the topic of several research reports. Royal Bank of Canada restated a “buy” rating and set a $97.00 price objective on shares of Prestige Consumer Healthcare in a research report on Friday, March 15th. TheStreet lowered shares of Prestige Consumer Healthcare from a “c” rating to a “d+” rating in a report on Friday, May 10th. Desjardins lowered shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 target price on the stock. in a report on Wednesday, February 13th. Zacks Investment Research raised shares of Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, April 24th. Finally, ValuEngine raised shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a report on Monday, April 29th.
Institutional investors have recently made changes to their positions in the business. BlueMountain Capital Management LLC lifted its position in Prestige Consumer Healthcare by 228.6% during the 1st quarter. BlueMountain Capital Management LLC now owns 46,000 shares of the company’s stock valued at $1,376,000 after acquiring an additional 32,000 shares during the period. Man Group plc lifted its position in Prestige Consumer Healthcare by 8.8% during the 1st quarter. Man Group plc now owns 421,997 shares of the company’s stock valued at $12,621,000 after acquiring an additional 34,274 shares during the period. M&T Bank Corp purchased a new position in Prestige Consumer Healthcare during the 1st quarter valued at about $411,000. Macquarie Group Ltd. lifted its position in Prestige Consumer Healthcare by 9.5% during the 1st quarter. Macquarie Group Ltd. now owns 1,583,025 shares of the company’s stock valued at $47,348,000 after acquiring an additional 136,700 shares during the period. Finally, Premia Global Advisors LLC purchased a new position in Prestige Consumer Healthcare during the 1st quarter valued at about $26,000.
NYSE PBH traded down $0.54 on Friday, hitting $29.49. The stock had a trading volume of 5,465 shares, compared to its average volume of 424,244. Prestige Consumer Healthcare has a 52-week low of $26.25 and a 52-week high of $41.76. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.37 and a quick ratio of 1.43. The stock has a market capitalization of $1.56 billion, a PE ratio of 10.62, a P/E/G ratio of 1.71 and a beta of 0.96.
Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, May 9th. The company reported $0.72 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.70 by $0.02. The firm had revenue of $241.03 million for the quarter, compared to analysts’ expectations of $237.22 million. Prestige Consumer Healthcare had a negative net margin of 3.67% and a positive return on equity of 12.45%. The business’s quarterly revenue was down 5.8% on a year-over-year basis. During the same quarter last year, the company posted $0.62 EPS. On average, research analysts anticipate that Prestige Consumer Healthcare will post 2.81 EPS for the current year.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Read More: Buy-Side Analysts
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.